Dimensional Fund Advisors
SRRA

Dimensional Fund Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Dimensional Fund Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44,204
Closed -$1.42M – 3563
2022
Q1 		$1.42M Buy
44,204
+4,899
+12% +$141K ﹤0.01% 2910
2021
Q4 		$854K Buy
39,305
+16,208
+70% +$357K ﹤0.01% 3062
2021
Q3 		$506K Buy
23,097
+4,968
+27% +$99.4K ﹤0.01% 3176
2021
Q2 		$354K Buy
18,129
+440
+2% +$8K ﹤0.01% 3232
2021
Q1 		$305K Buy
17,689
+4,242
+32% +$67.2K ﹤0.01% 3225
2020
Q4 		$216K Buy
13,447
+267
+2% +$3.71K ﹤0.01% 3209
2020
Q3 		$141K Sell
13,180
-77
-0.6% -$917 ﹤0.01% 3238
2020
Q2 		$161K Buy
13,257
+2,473
+23% +$30.7K ﹤0.01% 3234
2020
Q1 		$106K Buy
+10,784
New +$141K ﹤0.01% 3268
2019
Q4 		– Sell
-2,956
Closed -$46K – 3416
2019
Q3 		$46K Sell
2,956
-21,697
-88% -$415K ﹤0.01% 3386
2019
Q2 		$552K Hold
24,653
– – ﹤0.01% 3172
2019
Q1 		$1.69M Sell
24,653
-592
-2% -$38K ﹤0.01% 2930
2018
Q4 		$1.33M Sell
25,245
-954
-4% -$60.9K ﹤0.01% 2958
2018
Q3 		$1.78M Buy
26,199
+210
+0.8% +$19K ﹤0.01% 2949
2018
Q2 		$3.08M Buy
25,989
+7,184
+38% +$721K ﹤0.01% 2781
2018
Q1 		$1.56M Buy
18,805
+11,882
+172% +$1.35M ﹤0.01% 2909
2017
Q4 		$1.03M Buy
+6,923
New +$665K ﹤0.01% 2988

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors's SRRA Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 44,204 shares — an estimated $1.42M sold.

Dimensional Fund Advisors first reported a position in SRRA in Q4 2017 and held it in 17 quarters. The position peaked at $3.08M in Q2 2018. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 44,204 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $1.42M.
  • Dimensional Fund Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
  • Dimensional Fund Advisors's Sierra Oncology, Inc. Common Stock position peaked at $3.08M in Q2 2018.
  • 109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.